# BIOTRONIK Neuro acquires spinal cord stimulation IP from Soin Neuroscience

BIOTRONIK Neuro acquired a portfolio of intellectual property related to spinal cord stimulation from Soin Neuroscience. Financial terms were not disclosed. The acquisition builds on a prior research collaboration announced in December 2025.

- Type: Acquisition
- Announced: 2026-07-15
- Where: Centerville, Ohio; Lake Oswego, Oregon, United States
- Status: completed
- Products: spinal cord stimulation system, neuromodulation technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [BIOTRONIK Neuro](https://endata.com/companies/93055.md) (acquirer)
- [Soin Neuroscience](https://endata.com/companies/93056.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/press-releases/biotronik-neuro-acquires-spinal-cord-stimulation-system-from-soin-neuroscience), 2026-07-16: "Spinal cord stimulation has helped countless patients manage chronic pain without relying on opioids, but there is still enormous room to make the therapy smarter, more personalized, and dynamic."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/biotronik-neuro-soin-neurosciences-scs-ip/), 2026-07-16: "Dr Soin and his team have consistently pushed the boundaries of what personalised stimulation can look like, and this IP is a strong complement to our own SCS platform."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.